With Transparency Pledge, Glaxo Makes Promises No Other Drug Company Has Forbes by Matthew Herper 10/11/2012 In an unprecedented move that could signal dramatic changes in the drug industry, GlaxoSmithKline is promising to make detailed data from its clinical trials available to independent researchers so that scientists can draw their own conclusions about the safety […]
Epimenides was a Cretan who made one immortal statement: "All Cretans are liars." Douglas Hofstadter, Gödel, Escher, Bach Beware of Greeks bearing gifts Virgil, the Aeneid Glaxo Opens Door to Data on Research New York Times By KATIE THOMAS October 11, 2012 GlaxoSmithKline plans to open up much of its drug research in an apparent […]
UPDATED: Eli Lilly surges on conflicting data for Alzheimer’s drug solanezumab FierceBiotech By John Carroll October 8, 2012 Shares of Eli Lilly surged today after investigators spelled out the encouraging solanezumab data they plucked out of a secondary analysis of a group of patients with a mild form of the memory-wasting disease. As Lilly conceded […]
I always read Healthcare Renewal myself, but rarely pass it on because I assume you read it too, but there were a couple of recent posts that occurred to me when I was writing about Dr. Healy’s talk to the APA: Will Another Study on Physician Burnout Finally Lead to Addressing its Causes? Healthcare Renewal […]
"British psychiatrist and Big Pharma gadfly David Healy is so controversial amongst his colleagues that some have tried to have his medical license revoked — but there he was on Thursday, speaking at the American Psychiatric Association’s [APA] second largest annual meeting at a well-attended session on conflicts of interest. ‘It’s a miracle that I […]
“The key issue in the short term is access to data. We have to insist on that.” David Healy APA October 2012 It seems almost trivial that it comes down to something quite that simple, but that is the bottom line. A case that illustrates the point are the two articles by Robert Gibbons et […]
Just a sampler since I’m sure you’ll read it: Psychiatrist Contends the Field Is ‘Committing Professional Suicide’ Psychiatry — and medicine in general — has a dangerously close relationship with the pharmaceutical industry Time By Maia Szalavitz October 5, 2012 British psychiatrist and Big Pharma gadfly David Healy is so controversial amongst his colleagues that […]
The Military Can Do More To Prevent Suicides The Psychiatric Times By Allen Frances, MD October 8, 2012 James Dao reports in the October 8, 2012 New York Times that the military is considering 2 steps to reduce its startling rate of active duty suicides — which is approaching an unacceptable one suicide every day. […]
Just Like That? Trying To Discontinue Cymbalta Pharmalot By Ed Silverman October 8th, 2012 There has always been concern about discontinuing antidepressants and withdrawal symptoms. But a new analysis finds that anywhere from 44 percent to 50 percent of Cymbalta patients experienced withdrawal symptoms after clinical trials, and more than half were resolved within two […]
[click image for full schedule] At one of those meetings in the next few months, the DSM-5 is scheduled to be presented to the American Psychiatric Association’s Board of Trustees for final approval before going to print for the scheduled launch in May 2013. The web site, which hasn’t been touched in several months, still […]